Patents
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
07/2007
07/04/2007CN1990490A Dorzolamide intermediate preparation method
07/03/2007US7238818 Heterocyclic metallocenes and polymerization catalysts
07/03/2007US7238811 Chemical compounds
07/03/2007US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence
07/03/2007US7238701 Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disorders
07/03/2007US7238693 Gastrointestinal disorders; central nervous system disorders; cardiovascular disorders
07/03/2007US7238691 Piperidine derivatives and their use as modulators of chemokine (especially CCR3) activity
07/03/2007US7238690 Substituted heterocycle fused gamma-carbolines
07/03/2007CA2168021C Vasoconstrictive dihydrobenzopyran derivatives
06/2007
06/28/2007WO2007073095A1 Process for the preparation of (s)-(+)-clopidogrel on a solid-phase
06/28/2007WO2007072974A1 P2x4 receptor antagonist
06/28/2007WO2007072158A2 Pyrimidine derivatives for the treatment of abnormal cell growth
06/28/2007WO2007072150A2 Piperidine derivatives
06/28/2007WO2007072095A1 New compounds
06/28/2007WO2007072094A1 New compounds
06/28/2007WO2007072091A1 New compounds
06/28/2007WO2007072090A1 Thienopyridine derivatives as modulators of metabotropic glutamate receptors
06/28/2007US20070149615 Ketone compounds and compositions for cholesterol management and related uses
06/28/2007US20070149565 Nelfinavir conjugates and antibodies useful in immunoassay
06/28/2007US20070149553 2,3-Diphenylquinazolin-4(3H)-one compounds; anticarcinogenic agents can be synergistically combined with one or more active ingredients; side effect reduction
06/28/2007US20070148708 Protease inhibitor conjugates and antibodies useful in immunoassay
06/28/2007US20070148680 Detection of disease related genes
06/28/2007CA2634172A1 Piperidine derivatives
06/28/2007CA2630896A1 New compounds
06/28/2007CA2630890A1 Thienopyridine derivatives as modulators of metabotropic glutamate receptors
06/28/2007CA2630739A1 New compounds
06/28/2007CA2629984A1 New compounds
06/27/2007EP1801108A1 Morpholine compound
06/27/2007EP1799688A2 Fused thiophenes, methods for making fused thiophenes, and uses thereof
06/27/2007EP1799687A1 Novel thieno-pyridine and thieno-pyrimidine derivatives and their use as positive allosteric modulators of mglur2-receptors
06/27/2007EP1799653A2 Novel heterocycles
06/27/2007EP1590352B1 4-AMINOTHIENO [2,3-d] PYRIMIDINE-6-CARBONITRILE DERIVATIVES AS PDE7 INHIBITORS
06/27/2007CN1989131A Substituted thiophene derivatives as anti-cancer agents
06/27/2007CN1988934A Tetrahydropyridothiophenes
06/27/2007CN1988907A Dual small molecule inhibitors of cancer and angiogenesis
06/26/2007US7235674 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent
06/26/2007US7235661 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
06/26/2007US7235656 Anxiolytic agents with reduced sedative and ataxic effects
06/26/2007US7235566 Pyridinone derivatives for treatment of atherosclerosis
06/26/2007US7235561 Compound and a composition including such a compound
06/26/2007US7235557 Benzo-1,5-naphthyridine and benzo-2,5-naphthyridine derivatives are used as poly(ADP-ribose) polymerase inhibitors for treating vascular stroke, cerebral ischemia, heart ischemia/reperfusion injury and gout
06/21/2007WO2007070872A1 Kinase inhibitors and their uses
06/21/2007WO2007069635A1 Vla-4 inhibitory drug
06/21/2007WO2007068621A1 Novel fused pyrrole derivatives
06/21/2007WO2007068495A1 Salts of clopidogrel with polynions and their use for manufacturing pharmaceutical formulations
06/21/2007WO2007050353A3 Tricyclic compounds useful as oxytocin receptor agonists
06/21/2007US20070142637 Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug
06/21/2007US20070142438 (1S,5R)-1-[2-fluoro-4-(trifluoromethyl)phenyl]-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-3-azabicyclo[3.1.0]hexane; or(1S,5R)-3-{3-[(4-methyl-5-phenyl-4H-1,2,4-triazol-3-yl)oxy]propyl}-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane; schizophrenia
06/21/2007US20070142413 Pyrazole derivatives as inhibitors of receptor tyrosone kinases
06/21/2007US20070142377 Pyridyl Alkene and Pyridyl Alkine-Acid Amides as Cytostatics and Immunosuppressives
06/21/2007US20070142375 Pyrrolidine derivatives as factor xa inhibitors
06/21/2007US20070142374 e.g. 2-(4-Chlorophenyl)-N-{(3S)-1-[(1S)-1-methyl-2-morpholin-4-yl-2-oxoethyl]-2-oxopyrrolidin-3-yl}ethenesulfonamide; blood coagulation factor and trypsin-like serine protease inhibitor; anticoagulant, antiinflammatory agent; atherosclerotic plaque, myocardial infarction and unstable angina
06/21/2007US20070142351 Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
06/21/2007US20070142350 Therapeutic uses of derivatives of piperidinyl- and piperazinyl-alkyl carbamates
06/21/2007US20070142305 Antitumor agents; restenosis; antiarthritic agents; antidiabetic agents; platelet-derived growth factor receptor (PDGF-R)
06/21/2007US20070142301 inhibit HCV NS3/NS4a serine protease activity; modulate the processing of hepatitis C virus (HCV) polypeptide
06/21/2007US20070141643 Protease inhibitor conjugates and antibodies useful in immunoassay
06/21/2007US20070141624 Activity-based probes and methods of their preparation ans use
06/21/2007DE60121550T2 Pyrimidin-4-onderivat als LDL-PLA2 Inhibitor Pyrimidin-4-one derivative as LDL-PLA2 inhibitor
06/21/2007DE102005060690A1 Salze von Clopidogrel mit Polyanionen und ihre Verwendung zur Herstellung pharmazeutischer Formulierungen Salts of clopidogrel with polyanions and their use for the preparation of pharmaceutical formulations
06/21/2007CA2637740A1 Fused pyrrole derivatives
06/21/2007CA2633569A1 N-(5-membered heteroaromatic ring)-amido anti-viral compounds
06/21/2007CA2633093A1 Mglur1 antagonists as therapeutic agents
06/21/2007CA2633035A1 Kinase inhibitors and their uses
06/21/2007CA2631658A1 Salts of clopidogrel with polyanions and their use for manufacturing pharmaceutical formulations
06/20/2007EP1798231A2 Intermediate products for the preparation of antibacterial compounds
06/20/2007EP1797100A1 Nitrate esters and their use for mitigating cellular damage
06/20/2007EP1797099A1 Piperidinylamino-thieno[2,3-d] pyrimidine compounds
06/20/2007EP1797084A1 NOVEL HETEROCYCLIC NF-kB INHIBITORS
06/20/2007EP1797065A2 Acyclic 1,3-diamines and uses therefor
06/20/2007EP1796664A1 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
06/20/2007EP1796663A2 Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators
06/20/2007EP1796467A2 Imidazo{4,5-b}pyrazinone inhibitors of protein kinases
06/20/2007EP1575961B1 Method for the decarboxylation of dicarboxylic acids
06/20/2007EP1366043B1 2-heteroaryl-3,4-dihydro-2h-pyrrole derivatives and the use thereof as pesticides
06/20/2007CN1984916A Thienopyridine derivatives, production method and use thereof
06/14/2007WO2007067781A2 9-membered heterobicyclic compounds as inhibitors of protein kinases
06/14/2007WO2007066615A1 Novel activator of nuclear orphan receptor and use thereof
06/14/2007WO2007066353A2 Novel polymers of 3,4-propylenedioxythiophene derivatives with pendant functional groups
06/14/2007WO2007044050A3 1h-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
06/14/2007WO2006051397A8 Oligonucleotide probes
06/14/2007US20070135455 inhibitors Tie2 receptor tyrosine kinase; N-{3-[5-(4-aminothieno[2,3-d]pyrimidin-6-yl)-1-methyl-1H-imidazol-4-yl]phenyl}-N'-(3-fluorophenyl)urea; antiangiogenic effect; cancer, rheumatoid arthritis
06/14/2007US20070135454 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1)
06/14/2007US20070135434 Sulfonyloxy derivatives
06/14/2007US20070135408 Spiropiperidine derivatives for controlling pests
06/14/2007US20070134729 Novel antibacterial agents
06/14/2007US20070134161 Methods of determining beta-iii tubulin expression
06/13/2007EP1794145A1 Pyrazole compounds useful in the treatment of inflammation
06/13/2007EP1000040B1 Il-5 inhibiting 6-azauracil derivatives
06/13/2007CN1980937A Thienopyridone carboxamides and their medical use
06/12/2007US7230116 For use as pesticides, microbicides and herbicides
06/12/2007US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer
06/12/2007US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof
06/12/2007US7229990 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies.
06/07/2007WO2007063935A1 Aromatic compound
06/07/2007WO2007063934A1 Alicyclic heterocyclic compound
06/07/2007WO2006046031A8 Pharmaceutical compounds
06/07/2007US20070129373 Phthalazinone-piperidino-derivatives as PDE4 inhibitors
06/07/2007US20070129352 Novel crystal forms, methods for their preparation and method for preparation of olanzapine
06/06/2007EP1791816A1 Iodine-phenyl-substituted cyclic cetoenols
1 ... 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 ... 214